Entry of Christ into Jerusalem (van Dyck) 1958 as a gift for the Herron School of Art, which later evolved, in part, into the IMA. It is currently on view in the William C. Griffith Jr. and Carolyn C. Griffith Gallery and has the accession number 58.3. Entry of Christ into Jerusalem (van Dyck) Entry of Christ into Jerusalem is a 1617 oil painting by Flemish artist Anthony van Dyck, located in the Indianapolis Museum of Art, which is in Indianapolis, Indiana. It depicts Jesus entering Jerusalem as described in the Gospels, the event celebrated on Palm Sunday. Van Dyck's presentation of Jesus' entry into Jerusalem is
Christopher H. van Dyck brain. Studies of this ligand in early Alzheimer’s Disease patients have shown a loss of synapses from the perforant path, the connections between the entorhinal cortex and hippocampal formation needed for memory consolidation. van Dyck and the Yale ADRU have tested potential Alzheimer’s therapeutics for over 20 years. They have contributed to the successful development of memantine now in use for the treatment of mid-late stage Alzheimer’s Disease, and assess potential new therapeutic strategies, e.g. antibodies that reduce amyloid pathology such as Crenezumab, and based on the work of Dr. Stephen Strittmatter, an inhibitor of fyn. Dr. van Dyck serves